Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
Ashraf GM, Greig NH, Khan TA, Hassan I, Tabrez S, Shakil S, Sheikh IA, Zaidi SK, Akram M, Jabir NR, Firoz CK, Naeem A, Alhazza IM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2014;13(7):1280-93.
Similar articles
An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus .
Ali M, Firoz CK, Jabir NR, Rehan M, Khan MS, Tabrez S.
Endocr Metab Immune Disord Drug Targets. 2017 Dec 7. doi: 10.2174/1871530318666171207145003. [Epub ahead of print]
A putative association of interleukin-10 promoter polymorphisms with cardiovascular disease.
Tabrez S, Ali M, Jabir NR, Firoz CK, Ashraf GM, Hindawi S, Damanhouri GA, Nabil Alama M.
IUBMB Life. 2017 Jul;69(7):522-527. doi: 10.1002/iub.1637. Epub 2017 May 5.
Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.
Jabir NR, Firoz CK, Ahmed F, Kamal MA, Hindawi S, Damanhouri GA, Almehdar HA, Tabrez S.
Immunol Invest. 2017 Jul;46(5):526-535. doi: 10.1080/08820139.2017.1306866. Epub 2017 Apr 17.
Estimation of Interleukin-1β Promoter (-31 C/T and -511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients.
Tabrez S, Jabir NR, Firoz CK, Hindawi S, Shakil S, Damanhouri GA, Zaidi SK.
J Cell Biochem. 2017 Sep;118(9):2977-2982. doi: 10.1002/jcb.25958. Epub 2017 Apr 12.
Galectins-A Potential Target for Cardiovascular Therapy.
Ashraf GM, Perveen A, Zaidi SK, Ahmad A, Shakil S, Firoz CK, Jabir NR, Hassan I, Khan TA, Yarla NS, Tabrez S.
Curr Vasc Pharmacol. 2017;15(4):296-312. doi: 10.2174/1570161115666170201113046.
Assessment of IL-18 Serum Level and Its Promoter Polymorphisms in the Saudi Coronary Artery Disease (CAD) Patients.
Jabir NR, Firoz CK, Kamal MA, Damanhouri GA, Alama MN, Alam Q, Haque A, Almehdar HA, Tabrez S.
J Cell Biochem. 2017 Jul;118(7):1849-1854. doi: 10.1002/jcb.25870. Epub 2017 Feb 16.
Common Therapeutic Modalities Against Diabetes and Associated Cardiovascular Disease.
Jabir NR, Firoz CK, Ashraf GM, Zaidi SK, Shakil S, Kamal MA, Tabrez S.
Curr Vasc Pharmacol. 2017;15(4):365-373. doi: 10.2174/1570161115666170105125034.
Assessment of genetic diversity in IL-6 and RANTES promoters and their level in Saudi coronary artery disease patients.
Jabir NR, Firoz CK, Kamal MA, Damanhouri GA, Alama MN, Alzahrani AS, Almehdar HA, Tabrez S.
J Clin Lab Anal. 2017 Sep;31(5). doi: 10.1002/jcla.22092. Epub 2016 Nov 9.
Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome.
Jabir NR, Firoz CK, Khan MS, Zaidi SK, Ashraf GM, Shakil S, Kamal MA, Tabrez S.
Curr Drug Metab. 2017;18(1):62-68. doi: 10.2174/1389200217666160810155055.
Use of azoles containing natural products in cancer prevention and treatment: An overview.
Jabir NR, Firoz CK, Bhushan A, Tabrez S, Kamal MA.
Anticancer Agents Med Chem. 2016 May 20. [Epub ahead of print]
Neuroprotective Role of Steroidal Sex Hormones: An Overview.
Siddiqui AN, Siddiqui N, Khan RA, Kalam A, Jabir NR, Kamal MA, Firoz CK, Tabrez S.
CNS Neurosci Ther. 2016 May;22(5):342-50. doi: 10.1111/cns.12538. Epub 2016 Mar 25. Review.
Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases.
Jabir NR, Siddiqui AN, Firoz CK, Ashraf GM, Zaidi SK, Khan MS, Shakil S, Alama MN, Kamal MA, Tabrez S.
Curr Pharm Des. 2016;22(5):566-71. Review.
An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy.
Ashraf GM, Tabrez S, Jabir NR, Firoz CK, Ahmad S, Hassan I, Alexiou A, Kamal MA.
Curr Drug Metab. 2015;16(8):719-27. Review.
Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers.
Firoz CK, Jabir NR, Kamal MA, Alama MN, Damanhouri GA, Khan W, Alzahrani AS, Almehdar HA, Tabrez S.
IUBMB Life. 2015 Jun;67(6):453-9. doi: 10.1002/iub.1390. Epub 2015 Jun 18.
An overview on the correlation of neurological disorders with cardiovascular disease.
Firoz CK, Jabir NR, Khan MS, Mahmoud M, Shakil S, Damanhouri GA, Zaidi SK, Tabrez S, Kamal MA.
Saudi J Biol Sci. 2015 Jan;22(1):19-23. doi: 10.1016/j.sjbs.2014.09.003. Epub 2014 Sep 6. Review.
A Synopsis of Nano-Technological Approaches Toward Anti-Epilepsy Therapy: Present and Future Research Implications.
Jabir NR, Tabrez S, Firoz CK, Zaidi SK, Baeesa SS, Gan SH, Shakil S, Kamal MA.
Curr Drug Metab. 2015;16(5):336-45. Review.
Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.
Jabir NR, Firoz CK, Baeesa SS, Ashraf GM, Akhtar S, Kamal W, Kamal MA, Tabrez S.
CNS Neurosci Ther. 2015 Jan;21(1):1-7. doi: 10.1111/cns.12344. Epub 2014 Nov 15. Review.
Comparative study of non-high density lipoproteins cholesterol level and lipid profile in pre-diabetic and diabetic patients.
Banu S, Jabir NR, Manjunath NC, Firoz CK, Kamal MA, Khan MS, Tabrez S.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):402-7.
Alzheimer disease and type 2 diabetes mellitus: the link to tyrosine hydroxylase and probable nutritional strategies.
Aliev G, Shahida K, Gan SH, Firoz C, Khan A, Abuzenadah AM, Kamal W, Kamal MA, Tan Y, Qu X, Reale M.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):467-77. Review.
Filters: Manage Filters